My NCBI | Sign In
RSS Settings
  • Search: CYP17 AND breast cancer AND ("2002/04/29"[Edat] : "2003/04/29"...

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Preparation and pharmacological profile of 7-(alpha-azolylbenzyl)-1H-indoles and indolines as new aromatase inhibitors.

    Marchand P, Le Borgne M, Palzer M, Le Baut G, Hartmann RW.

    Bioorg Med Chem Lett. 2003 May 5;13(9):1553-5.PMID: 12699753 [PubMed - indexed for MEDLINE]Related articles

    2.

    The CYP3A4*1B variant is related to the onset of puberty, a known risk factor for the development of breast cancer.

    Kadlubar FF, Berkowitz GS, Delongchamp RR, Wang C, Green BL, Tang G, Lamba J, Schuetz E, Wolff MS.

    Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):327-31.PMID: 12692107 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.

    Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL.

    Genet Epidemiol. 2003 Apr;24(3):161-72.PMID: 12652520 [PubMed - indexed for MEDLINE]Related articles

    4.

    CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status.

    Gudmundsdottir K, Thorlacius S, Jonasson JG, Sigfusson BF, Tryggvadottir L, Eyfjord JE.

    Br J Cancer. 2003 Mar 24;88(6):933-6.PMID: 12644832 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.

    Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG.

    Breast Cancer Res. 2003;5(2):R45-51. Epub 2003 Jan 29.PMID: 12631398 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Polymorphisms in steroid hormone pathway genes and mammographic density.

    Haiman CA, Hankinson SE, De Vivo I, Guillemette C, Ishibe N, Hunter DJ, Byrne C.

    Breast Cancer Res Treat. 2003 Jan;77(1):27-36.PMID: 12602902 [PubMed - indexed for MEDLINE]Related articles

    7.

    HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore.

    Wu AH, Seow A, Arakawa K, Van Den Berg D, Lee HP, Yu MC.

    Int J Cancer. 2003 Apr 20;104(4):450-7.PMID: 12584742 [PubMed - indexed for MEDLINE]Related articles

    8.

    Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women.

    Kang D.

    J Biochem Mol Biol. 2003 Jan 31;36(1):28-34. Review.PMID: 12542972 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Research on breast cancer susceptibility genes]

    Ye J, Shan BE.

    Ai Zheng. 2002 Sep;21(9):1035-9. Review. Chinese. PMID: 12508556 [PubMed - indexed for MEDLINE]Related articles

    10.

    The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women.

    McCann SE, Moysich KB, Freudenheim JL, Ambrosone CB, Shields PG.

    J Nutr. 2002 Oct;132(10):3036-41.PMID: 12368392 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

    Feigelson HS, McKean-Cowdin R, Henderson BE.

    Mutagenesis. 2002 Sep;17(5):445-6; author reply 447-8. No abstract available. PMID: 12202634 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Genetic determinants of mammographic density.

    Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G.

    Breast Cancer Res. 2002;4(3):R5. Epub 2002 Mar 25.PMID: 12052257 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    1-[(Benzofuran-2-yl)phenylmethyl]triazoles as steroidogenic inhibitors: synthesis and in vitro inhibition of human placental CYP19 aromatase.

    Vinh TK, Yee SW, Kirby AJ, Nicholls PJ, Simons C.

    Anticancer Drug Des. 2001 Aug-Oct;16(4-5):217-25.PMID: 12049480 [PubMed - indexed for MEDLINE]Related articles

    14.

    Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.

    Garner EI, Stokes EE, Berkowitz RS, Mok SC, Cramer DW.

    Cancer Res. 2002 Jun 1;62(11):3058-62.PMID: 12036914 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effect of germ-line genetic variation on breast cancer survival in a population-based study.

    Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP.

    Cancer Res. 2002 Jun 1;62(11):3052-7.PMID: 12036913 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Distribution of family history of a disease as a function of mode of inheritance, genetic relative hazard, allele frequency and disease status of the proband, with application to female breast cancer.

    Cui J, Hopper JL.

    J Epidemiol Biostat. 2001;6(4):331-42.PMID: 12036267 [PubMed - indexed for MEDLINE]Related articles

    17.

    Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders.

    Huber JC, Schneeberger C, Tempfer CB.

    Maturitas. 2002 May 20;42(1):1-12. Review.PMID: 12020974 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    3 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity